Lakefront Biotherapeutics (LKFT) Tax Provisions (2018 - 2020)

Lakefront Biotherapeutics (LKFT) has 3 years of Tax Provisions data on file, last reported at $370923.5 in Q1 2020.

• Tax Provisions for Q1 2020 came in at $370923.5, up 379.91% year-over-year; the trailing twelve-month figure through Mar 2020 was $20.1 million (up 2040.13% YoY), and the FY2025 annual result was -$21.7 million, down 1025.03% from the prior year.
• Tax Provisions eased to $370923.5 in Q1 2020 per LKFT's latest filing, from $18.3 million in the prior quarter.
• Over five years, Tax Provisions peaked at $18.3 million in Q4 2019 and troughed at -$558302.0 in Q3 2018.
• A 3-year average of $2.8 million and a median of $89508.3 in 2018 frame the typical range for Tax Provisions.
• On a YoY basis, Tax Provisions climbed as much as 1276.32% in 2019 and fell as far as 1.47% in 2019.
• A 3-year view of Tax Provisions shows it stood at $1.3 million in 2018, then jumped by 1276.32% to $18.3 million in 2019, then sank by 97.97% to $370923.5 in 2020.
• Business Quant data shows LKFT's Tax Provisions at $370923.5 in Q1 2020, $18.3 million in Q4 2019, and $77290.8 in Q1 2019.